Form 4: Charles River Labs Director Trades Shares

Charles River Laboratories International, Inc. Director Craig B. Thompson reported a transaction involving company common stock.

Summary

• Director Craig B. Thompson acquired 1,438 shares of common stock in Charles River Laboratories International, Inc. on May 8, 2026.
• The acquisition was made at a price of $177.62 per share.
• Following this transaction, Mr. Thompson beneficially owns 3,851 shares of common stock directly.
• The filing also notes unvested restricted stock units that vest on May 8, 2027, or the day before the company's next annual shareholder meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard insider transaction without significant positive or negative implications beyond the director's personal investment.

Positives

• Director's acquisition of shares can be interpreted as a positive signal of confidence in the company's future prospects.
• The acquisition of 1,438 shares at $177.62 per share indicates a direct investment by a key insider.

Risks

• The unvested restricted stock units have a vesting schedule tied to the company's next annual meeting, introducing a potential time-based risk for the executive.
• The transaction price of $177.62 per share may represent a point of reference for future price expectations.

Future Outlook

The filing mentions unvested restricted stock units that will vest on May 8, 2027, or the business day prior to the Company's next annual meeting of shareholders, indicating future compensation events.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the buying and selling activities of company directors and officers. This specific filing indicates a direct purchase of common stock by a director.

Stakeholder Impact

• Shareholders: The transaction may be viewed as a signal of confidence by a director, potentially influencing investor sentiment.
• Management: The vesting of restricted stock units indicates ongoing compensation and incentive structures for management.

Next Steps

• Vesting of unvested restricted stock units on May 8, 2027, or the business day prior to the Company's next annual meeting of shareholders.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Charles River Laboratories, Craig B. Thompson, Common Stock, Beneficial Ownership, Restricted Stock Units